Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Attention Deficit Disorder with Hyperactivity | 248 | 2024 | 3701 | 17.010 |
Why?
|
Central Nervous System Stimulants | 98 | 2024 | 1176 | 13.380 |
Why?
|
Substance-Related Disorders | 111 | 2024 | 4404 | 9.900 |
Why?
|
Methylphenidate | 39 | 2024 | 488 | 4.970 |
Why?
|
Propylamines | 27 | 2012 | 161 | 3.370 |
Why?
|
Adrenergic Uptake Inhibitors | 20 | 2014 | 186 | 2.620 |
Why?
|
Conduct Disorder | 16 | 2023 | 245 | 2.490 |
Why?
|
Opioid-Related Disorders | 22 | 2024 | 2141 | 2.340 |
Why?
|
Bipolar Disorder | 46 | 2023 | 5083 | 1.840 |
Why?
|
Methamphetamine | 3 | 2024 | 165 | 1.720 |
Why?
|
Adolescent | 220 | 2024 | 87819 | 1.670 |
Why?
|
Psychotropic Drugs | 14 | 2015 | 883 | 1.650 |
Why?
|
Guanfacine | 7 | 2020 | 51 | 1.610 |
Why?
|
Comorbidity | 83 | 2024 | 10477 | 1.560 |
Why?
|
Executive Function | 7 | 2024 | 1375 | 1.510 |
Why?
|
Antidepressive Agents, Tricyclic | 21 | 2006 | 431 | 1.460 |
Why?
|
Alcoholism | 15 | 2021 | 1965 | 1.300 |
Why?
|
Child | 203 | 2024 | 79782 | 1.280 |
Why?
|
Amphetamines | 11 | 2008 | 143 | 1.270 |
Why?
|
Delayed-Action Preparations | 25 | 2021 | 961 | 1.260 |
Why?
|
Adolescent Psychiatry | 4 | 2024 | 158 | 1.220 |
Why?
|
Students | 8 | 2023 | 1729 | 1.210 |
Why?
|
Smoking | 19 | 2016 | 9036 | 1.090 |
Why?
|
Desipramine | 16 | 2005 | 182 | 1.070 |
Why?
|
Mental Disorders | 35 | 2022 | 6802 | 1.070 |
Why?
|
Child Psychiatry | 6 | 2024 | 226 | 1.020 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 2 | 2016 | 91 | 0.990 |
Why?
|
Humans | 359 | 2024 | 757566 | 0.940 |
Why?
|
Pyrrolidines | 4 | 2010 | 337 | 0.940 |
Why?
|
Psychiatric Status Rating Scales | 52 | 2015 | 6014 | 0.940 |
Why?
|
Bupropion | 11 | 2006 | 304 | 0.940 |
Why?
|
Opiate Substitution Treatment | 7 | 2023 | 436 | 0.930 |
Why?
|
Self Medication | 6 | 2024 | 117 | 0.930 |
Why?
|
Prescription Drugs | 5 | 2024 | 626 | 0.900 |
Why?
|
Cocaine | 3 | 2024 | 958 | 0.900 |
Why?
|
Amphetamine-Related Disorders | 1 | 2024 | 80 | 0.880 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2024 | 623 | 0.800 |
Why?
|
Antidepressive Agents | 19 | 2014 | 2889 | 0.790 |
Why?
|
Female | 231 | 2024 | 389943 | 0.770 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 9 | 2023 | 306 | 0.740 |
Why?
|
Parents | 13 | 2024 | 3548 | 0.740 |
Why?
|
Analgesics, Opioid | 15 | 2024 | 3762 | 0.730 |
Why?
|
Male | 219 | 2024 | 358180 | 0.730 |
Why?
|
Tic Disorders | 8 | 2024 | 136 | 0.730 |
Why?
|
Antidepressive Agents, Second-Generation | 6 | 2005 | 489 | 0.720 |
Why?
|
Adolescent Behavior | 10 | 2024 | 1185 | 0.710 |
Why?
|
Mood Disorders | 10 | 2019 | 1123 | 0.700 |
Why?
|
Alcohol-Induced Disorders | 3 | 2011 | 27 | 0.690 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2021 | 166 | 0.690 |
Why?
|
Tourette Syndrome | 11 | 2017 | 395 | 0.690 |
Why?
|
Heart Rate | 13 | 2022 | 4172 | 0.680 |
Why?
|
Substance Abuse, Intravenous | 3 | 2019 | 529 | 0.680 |
Why?
|
Indans | 3 | 2006 | 92 | 0.670 |
Why?
|
Adult | 135 | 2024 | 219725 | 0.660 |
Why?
|
Clonidine | 11 | 2006 | 169 | 0.650 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 2019 | 26 | 0.650 |
Why?
|
Child of Impaired Parents | 6 | 2018 | 459 | 0.640 |
Why?
|
Buprenorphine | 7 | 2023 | 654 | 0.640 |
Why?
|
Young Adult | 43 | 2024 | 58755 | 0.640 |
Why?
|
Inpatients | 4 | 2024 | 2536 | 0.630 |
Why?
|
Double-Blind Method | 35 | 2021 | 12261 | 0.630 |
Why?
|
Family Health | 10 | 2014 | 1256 | 0.630 |
Why?
|
Methadone | 8 | 2023 | 320 | 0.630 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2015 | 297 | 0.620 |
Why?
|
Phenobarbital | 1 | 2019 | 189 | 0.610 |
Why?
|
Drug Administration Schedule | 24 | 2017 | 4845 | 0.610 |
Why?
|
Postpartum Period | 3 | 2023 | 1167 | 0.600 |
Why?
|
Dose-Response Relationship, Drug | 26 | 2017 | 10749 | 0.590 |
Why?
|
Child Behavior | 3 | 2019 | 847 | 0.580 |
Why?
|
Benzodiazepines | 5 | 2024 | 1130 | 0.580 |
Why?
|
Marijuana Smoking | 2 | 2017 | 258 | 0.570 |
Why?
|
Adrenergic alpha-Agonists | 4 | 2011 | 177 | 0.570 |
Why?
|
Psychopharmacology | 3 | 2024 | 148 | 0.570 |
Why?
|
Nicotinic Agonists | 4 | 2010 | 265 | 0.570 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 16 | 2016 | 1988 | 0.560 |
Why?
|
Social Problems | 3 | 2022 | 109 | 0.560 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 186 | 0.550 |
Why?
|
Outpatients | 3 | 2023 | 1590 | 0.540 |
Why?
|
Social Environment | 2 | 2020 | 1019 | 0.530 |
Why?
|
Blood Pressure | 12 | 2022 | 8453 | 0.520 |
Why?
|
Mothers | 5 | 2023 | 2187 | 0.520 |
Why?
|
Family | 14 | 2019 | 3188 | 0.510 |
Why?
|
Patient Dropouts | 2 | 2017 | 412 | 0.510 |
Why?
|
Autistic Disorder | 2 | 2021 | 1216 | 0.500 |
Why?
|
Cannabinoids | 1 | 2017 | 172 | 0.500 |
Why?
|
Treatment Outcome | 57 | 2022 | 64242 | 0.490 |
Why?
|
Anxiety Disorders | 17 | 2022 | 2712 | 0.480 |
Why?
|
Drug Therapy, Combination | 14 | 2016 | 6292 | 0.480 |
Why?
|
Psychopathology | 5 | 2024 | 429 | 0.480 |
Why?
|
Nortriptyline | 7 | 2000 | 79 | 0.480 |
Why?
|
Prevalence | 26 | 2024 | 15640 | 0.480 |
Why?
|
Hypnotics and Sedatives | 3 | 2019 | 1176 | 0.470 |
Why?
|
Risk Factors | 58 | 2024 | 73708 | 0.470 |
Why?
|
Psychotherapy | 8 | 2024 | 1640 | 0.470 |
Why?
|
Pregnancy Complications | 5 | 2024 | 2940 | 0.460 |
Why?
|
Placebos | 13 | 2011 | 1661 | 0.460 |
Why?
|
Marijuana Abuse | 4 | 2022 | 410 | 0.460 |
Why?
|
Child Behavior Disorders | 10 | 2002 | 805 | 0.450 |
Why?
|
Depressive Disorder | 18 | 2007 | 3726 | 0.450 |
Why?
|
Dextroamphetamine | 3 | 2012 | 134 | 0.440 |
Why?
|
Age Factors | 36 | 2020 | 18326 | 0.440 |
Why?
|
Naltrexone | 4 | 2023 | 317 | 0.430 |
Why?
|
Case-Control Studies | 27 | 2020 | 22022 | 0.430 |
Why?
|
Diagnosis, Dual (Psychiatry) | 9 | 2014 | 303 | 0.420 |
Why?
|
Schools | 6 | 2023 | 1482 | 0.420 |
Why?
|
Isoxazoles | 2 | 2007 | 230 | 0.410 |
Why?
|
Cross-Over Studies | 13 | 2015 | 2048 | 0.410 |
Why?
|
Nootropic Agents | 2 | 2020 | 157 | 0.400 |
Why?
|
Pyridines | 3 | 2010 | 2864 | 0.400 |
Why?
|
Massachusetts | 15 | 2024 | 8815 | 0.390 |
Why?
|
Sertraline | 2 | 2006 | 208 | 0.390 |
Why?
|
Tobacco Use Disorder | 2 | 2008 | 698 | 0.390 |
Why?
|
Neuropsychological Tests | 19 | 2018 | 7024 | 0.390 |
Why?
|
Antipsychotic Agents | 8 | 2020 | 3060 | 0.380 |
Why?
|
Cholinesterase Inhibitors | 2 | 2006 | 239 | 0.380 |
Why?
|
Antimanic Agents | 5 | 2009 | 520 | 0.380 |
Why?
|
Piperidines | 3 | 2006 | 1639 | 0.380 |
Why?
|
Age of Onset | 12 | 2023 | 3296 | 0.380 |
Why?
|
Personality Assessment | 13 | 2012 | 650 | 0.370 |
Why?
|
Aggression | 5 | 2023 | 746 | 0.370 |
Why?
|
Alcohol-Related Disorders | 4 | 2019 | 235 | 0.360 |
Why?
|
Cognition | 10 | 2023 | 6952 | 0.360 |
Why?
|
Perioperative Care | 1 | 2018 | 1023 | 0.360 |
Why?
|
Universities | 5 | 2020 | 986 | 0.360 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12397 | 0.350 |
Why?
|
Cholinergic Agents | 4 | 2004 | 96 | 0.350 |
Why?
|
Amphetamine | 4 | 2019 | 224 | 0.340 |
Why?
|
Pemoline | 4 | 2005 | 18 | 0.340 |
Why?
|
Obsessive-Compulsive Disorder | 5 | 2003 | 1489 | 0.330 |
Why?
|
Medication Adherence | 1 | 2021 | 2155 | 0.330 |
Why?
|
Fluoxetine | 3 | 2002 | 733 | 0.330 |
Why?
|
Central Nervous System Depressants | 2 | 2011 | 164 | 0.330 |
Why?
|
Motivation | 7 | 2020 | 1996 | 0.320 |
Why?
|
Delivery of Health Care | 4 | 2024 | 5325 | 0.320 |
Why?
|
Student Dropouts | 2 | 2018 | 27 | 0.310 |
Why?
|
Prescriptions | 5 | 2024 | 386 | 0.310 |
Why?
|
Tachycardia | 3 | 2005 | 600 | 0.310 |
Why?
|
Pilot Projects | 9 | 2024 | 8550 | 0.310 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2017 | 1373 | 0.300 |
Why?
|
Depressive Disorder, Major | 5 | 2022 | 4744 | 0.290 |
Why?
|
Norepinephrine | 2 | 2008 | 897 | 0.290 |
Why?
|
United States | 29 | 2024 | 71902 | 0.290 |
Why?
|
Attention | 6 | 2013 | 2387 | 0.280 |
Why?
|
Administration, Cutaneous | 4 | 2015 | 711 | 0.280 |
Why?
|
Siblings | 5 | 2016 | 824 | 0.270 |
Why?
|
Cannabis | 2 | 2023 | 436 | 0.270 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1658 | 0.260 |
Why?
|
Hostility | 1 | 2006 | 183 | 0.260 |
Why?
|
Exercise Test | 2 | 2012 | 2121 | 0.250 |
Why?
|
Self Report | 5 | 2024 | 3709 | 0.250 |
Why?
|
Antihypertensive Agents | 5 | 2006 | 2018 | 0.250 |
Why?
|
Psychometrics | 5 | 2020 | 3051 | 0.250 |
Why?
|
Qualitative Research | 3 | 2024 | 2973 | 0.250 |
Why?
|
Synaptic Transmission | 2 | 2008 | 1168 | 0.240 |
Why?
|
Follow-Up Studies | 29 | 2018 | 39020 | 0.240 |
Why?
|
Hypertension | 4 | 2012 | 8502 | 0.240 |
Why?
|
Drug Prescriptions | 5 | 2024 | 1666 | 0.240 |
Why?
|
Death, Sudden, Cardiac | 3 | 2006 | 1553 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 2 | 2018 | 3165 | 0.240 |
Why?
|
Antisocial Personality Disorder | 5 | 2023 | 224 | 0.230 |
Why?
|
Dietary Supplements | 1 | 2017 | 3387 | 0.230 |
Why?
|
Neonatal Abstinence Syndrome | 2 | 2023 | 108 | 0.230 |
Why?
|
Middle Aged | 44 | 2024 | 219192 | 0.230 |
Why?
|
Retrospective Studies | 31 | 2024 | 79984 | 0.230 |
Why?
|
Personality Development | 2 | 1995 | 244 | 0.230 |
Why?
|
Ethanol | 2 | 2011 | 1324 | 0.220 |
Why?
|
Clomipramine | 2 | 1995 | 54 | 0.220 |
Why?
|
Pregnancy | 16 | 2024 | 29712 | 0.220 |
Why?
|
Electrocardiography | 9 | 2009 | 6363 | 0.220 |
Why?
|
Homeless Youth | 1 | 2024 | 46 | 0.220 |
Why?
|
Ambulatory Care | 8 | 2021 | 2767 | 0.220 |
Why?
|
Longitudinal Studies | 17 | 2024 | 14473 | 0.220 |
Why?
|
Interview, Psychological | 6 | 2016 | 809 | 0.220 |
Why?
|
Dopamine | 3 | 2008 | 1599 | 0.220 |
Why?
|
Referral and Consultation | 6 | 2002 | 3579 | 0.210 |
Why?
|
Valproic Acid | 4 | 2009 | 442 | 0.210 |
Why?
|
Residential Treatment | 1 | 2024 | 107 | 0.210 |
Why?
|
Sex Factors | 15 | 2016 | 10495 | 0.210 |
Why?
|
Legislation, Drug | 1 | 2024 | 214 | 0.200 |
Why?
|
Reference Values | 3 | 2019 | 4918 | 0.200 |
Why?
|
Nicotine | 1 | 2007 | 677 | 0.200 |
Why?
|
Checklist | 2 | 2020 | 827 | 0.190 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2006 | 600 | 0.190 |
Why?
|
Social Work | 1 | 2023 | 159 | 0.190 |
Why?
|
Narcotic Antagonists | 1 | 2006 | 583 | 0.190 |
Why?
|
Tranquilizing Agents | 2 | 2018 | 58 | 0.190 |
Why?
|
Cognition Disorders | 8 | 2011 | 3975 | 0.190 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2008 | 415 | 0.190 |
Why?
|
Alcohol Drinking | 2 | 2011 | 4019 | 0.190 |
Why?
|
Sex Distribution | 5 | 2008 | 2278 | 0.190 |
Why?
|
Emotions | 1 | 2013 | 2732 | 0.180 |
Why?
|
Psychiatry | 2 | 2024 | 1690 | 0.180 |
Why?
|
Clinical Trials as Topic | 7 | 2014 | 7982 | 0.180 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 25924 | 0.180 |
Why?
|
Affective Symptoms | 2 | 2011 | 416 | 0.180 |
Why?
|
Time Factors | 11 | 2019 | 39811 | 0.180 |
Why?
|
Cocaine-Related Disorders | 1 | 2024 | 461 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6470 | 0.180 |
Why?
|
Risk-Taking | 1 | 2006 | 1033 | 0.180 |
Why?
|
Cannabidiol | 1 | 2021 | 117 | 0.170 |
Why?
|
Educational Status | 2 | 2018 | 2511 | 0.170 |
Why?
|
Nausea | 3 | 2017 | 679 | 0.170 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2005 | 578 | 0.170 |
Why?
|
Substance Abuse Detection | 3 | 2007 | 301 | 0.160 |
Why?
|
Poison Control Centers | 1 | 2019 | 76 | 0.160 |
Why?
|
Severity of Illness Index | 17 | 2015 | 15781 | 0.160 |
Why?
|
Child, Preschool | 28 | 2023 | 42045 | 0.160 |
Why?
|
Prospective Studies | 21 | 2024 | 54092 | 0.160 |
Why?
|
Heart | 1 | 2012 | 4382 | 0.160 |
Why?
|
Enuresis | 1 | 1998 | 50 | 0.160 |
Why?
|
Mass Screening | 6 | 2021 | 5412 | 0.160 |
Why?
|
Focus Groups | 1 | 2024 | 1380 | 0.150 |
Why?
|
World Health Organization | 1 | 2024 | 1312 | 0.150 |
Why?
|
Parenting | 2 | 2023 | 695 | 0.150 |
Why?
|
Social Class | 6 | 2016 | 1996 | 0.140 |
Why?
|
Protriptyline | 1 | 1996 | 7 | 0.140 |
Why?
|
Anti-Anxiety Agents | 1 | 1999 | 397 | 0.140 |
Why?
|
Analysis of Variance | 4 | 2016 | 6230 | 0.140 |
Why?
|
Drug Tolerance | 1 | 2018 | 367 | 0.140 |
Why?
|
Depression | 3 | 2018 | 8049 | 0.130 |
Why?
|
Diagnosis, Differential | 11 | 2014 | 12951 | 0.130 |
Why?
|
Drug Interactions | 7 | 2003 | 1415 | 0.130 |
Why?
|
Resilience, Psychological | 1 | 2024 | 771 | 0.130 |
Why?
|
Drug Monitoring | 3 | 2010 | 960 | 0.130 |
Why?
|
Maternal Exposure | 1 | 2023 | 1045 | 0.130 |
Why?
|
Dwarfism | 1 | 1996 | 137 | 0.130 |
Why?
|
Administration, Oral | 4 | 2010 | 3994 | 0.130 |
Why?
|
Statistics as Topic | 4 | 2016 | 2357 | 0.130 |
Why?
|
Disease Susceptibility | 2 | 2019 | 1787 | 0.120 |
Why?
|
Confidence Intervals | 3 | 2008 | 2922 | 0.120 |
Why?
|
Cyclohexanols | 1 | 1995 | 126 | 0.120 |
Why?
|
Transdermal Patch | 1 | 2015 | 51 | 0.120 |
Why?
|
Intention | 1 | 2017 | 340 | 0.120 |
Why?
|
Patient Satisfaction | 2 | 2024 | 3440 | 0.120 |
Why?
|
Drug Therapy | 1 | 2017 | 503 | 0.120 |
Why?
|
Databases as Topic | 2 | 2006 | 472 | 0.120 |
Why?
|
Child Abuse | 1 | 2023 | 1067 | 0.120 |
Why?
|
Vomiting | 1 | 2017 | 652 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2017 | 10135 | 0.120 |
Why?
|
Health Surveys | 5 | 2020 | 4056 | 0.110 |
Why?
|
Heroin Dependence | 1 | 2014 | 172 | 0.110 |
Why?
|
Central Nervous System Agents | 1 | 2014 | 75 | 0.110 |
Why?
|
Growth Disorders | 1 | 1998 | 653 | 0.110 |
Why?
|
Demography | 3 | 2008 | 1645 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5194 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1098 | 0.110 |
Why?
|
Logistic Models | 8 | 2023 | 13221 | 0.110 |
Why?
|
Histamine Agonists | 1 | 2012 | 13 | 0.100 |
Why?
|
Psychotic Disorders | 3 | 2011 | 3197 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7366 | 0.100 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 931 | 0.100 |
Why?
|
Developmental Disabilities | 2 | 2010 | 1504 | 0.100 |
Why?
|
Social Behavior | 3 | 2006 | 1132 | 0.100 |
Why?
|
Carbamazepine | 2 | 2006 | 224 | 0.100 |
Why?
|
Incidence | 8 | 2020 | 21217 | 0.100 |
Why?
|
Peer Group | 1 | 2017 | 679 | 0.100 |
Why?
|
Tricuspid Valve | 1 | 2014 | 408 | 0.100 |
Why?
|
Triazoles | 1 | 1997 | 902 | 0.100 |
Why?
|
Odds Ratio | 5 | 2020 | 9624 | 0.100 |
Why?
|
School Health Services | 1 | 2015 | 381 | 0.090 |
Why?
|
Infant | 7 | 2023 | 36045 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2023 | 2496 | 0.090 |
Why?
|
Liver Function Tests | 2 | 2009 | 522 | 0.090 |
Why?
|
Achievement | 5 | 2009 | 289 | 0.090 |
Why?
|
Remedial Teaching | 1 | 2010 | 16 | 0.090 |
Why?
|
Risk | 3 | 2016 | 9590 | 0.090 |
Why?
|
Long-Term Care | 3 | 2005 | 632 | 0.090 |
Why?
|
Chi-Square Distribution | 6 | 2011 | 3415 | 0.090 |
Why?
|
Quinazolinones | 1 | 2012 | 221 | 0.090 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1429 | 0.090 |
Why?
|
Anxiety | 4 | 2021 | 4532 | 0.090 |
Why?
|
Endocarditis, Bacterial | 1 | 2014 | 442 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2019 | 1382 | 0.090 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2414 | 0.090 |
Why?
|
Thioridazine | 1 | 1990 | 33 | 0.090 |
Why?
|
Body Height | 1 | 1996 | 1568 | 0.090 |
Why?
|
Communication | 2 | 2019 | 3841 | 0.090 |
Why?
|
Metabolic Clearance Rate | 4 | 2012 | 361 | 0.090 |
Why?
|
Interviews as Topic | 4 | 2024 | 2673 | 0.090 |
Why?
|
Obstetric Labor Complications | 1 | 2012 | 236 | 0.080 |
Why?
|
Trichotillomania | 1 | 1992 | 177 | 0.080 |
Why?
|
Osmotic Pressure | 1 | 2010 | 137 | 0.080 |
Why?
|
Hemodynamics | 2 | 2001 | 4156 | 0.080 |
Why?
|
Parent-Child Relations | 2 | 2008 | 759 | 0.080 |
Why?
|
Corticosterone | 4 | 1985 | 305 | 0.080 |
Why?
|
Infant, Newborn | 7 | 2023 | 26176 | 0.080 |
Why?
|
Independent Living | 1 | 2013 | 567 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 10 | 2016 | 17767 | 0.080 |
Why?
|
Combined Modality Therapy | 6 | 2005 | 8512 | 0.080 |
Why?
|
Intelligence Tests | 2 | 2007 | 500 | 0.080 |
Why?
|
Cardiovascular System | 2 | 2006 | 835 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3317 | 0.080 |
Why?
|
Panic Disorder | 2 | 2009 | 613 | 0.080 |
Why?
|
Patient Care Team | 3 | 2008 | 2505 | 0.080 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2008 | 30 | 0.080 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2008 | 69 | 0.080 |
Why?
|
Placebo Effect | 2 | 2009 | 518 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1415 | 0.080 |
Why?
|
Safety | 2 | 2006 | 1147 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7225 | 0.080 |
Why?
|
Dexamethasone | 3 | 1985 | 1927 | 0.070 |
Why?
|
Methionine Sulfoximine | 2 | 1984 | 12 | 0.070 |
Why?
|
Hydrocortisone | 3 | 1985 | 1802 | 0.070 |
Why?
|
Intelligence | 3 | 2011 | 921 | 0.070 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 324 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2014 | 1033 | 0.070 |
Why?
|
Catechol O-Methyltransferase | 1 | 2009 | 251 | 0.070 |
Why?
|
Wechsler Scales | 3 | 2008 | 257 | 0.070 |
Why?
|
Monoamine Oxidase Inhibitors | 2 | 2004 | 156 | 0.070 |
Why?
|
Mianserin | 1 | 2006 | 50 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2794 | 0.070 |
Why?
|
Epilepsy | 2 | 2017 | 3270 | 0.070 |
Why?
|
Psychological Tests | 4 | 2011 | 639 | 0.070 |
Why?
|
Receptors, Dopamine D1 | 1 | 2008 | 293 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2010 | 1539 | 0.070 |
Why?
|
Self Administration | 1 | 2008 | 390 | 0.070 |
Why?
|
Osmosis | 1 | 2006 | 103 | 0.070 |
Why?
|
Body Weight | 1 | 1996 | 4602 | 0.060 |
Why?
|
Primary Health Care | 2 | 2021 | 4652 | 0.060 |
Why?
|
Nicotinic Antagonists | 1 | 2006 | 94 | 0.060 |
Why?
|
Receptors, Dopamine D2 | 1 | 2008 | 485 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 15398 | 0.060 |
Why?
|
Memory, Short-Term | 3 | 2008 | 980 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2017 | 1079 | 0.060 |
Why?
|
Self-Help Groups | 1 | 2006 | 188 | 0.060 |
Why?
|
Tachycardia, Supraventricular | 1 | 2008 | 273 | 0.060 |
Why?
|
Affect | 2 | 2003 | 1480 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3428 | 0.060 |
Why?
|
Mother-Child Relations | 1 | 2009 | 494 | 0.060 |
Why?
|
Length of Stay | 1 | 2019 | 6384 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2009 | 596 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6724 | 0.060 |
Why?
|
Narcotics | 1 | 2007 | 336 | 0.060 |
Why?
|
Psychophysiologic Disorders | 1 | 2006 | 221 | 0.060 |
Why?
|
Receptors, Nicotinic | 1 | 2007 | 495 | 0.060 |
Why?
|
Cohort Studies | 5 | 2022 | 41190 | 0.060 |
Why?
|
Sex Characteristics | 2 | 2005 | 2621 | 0.060 |
Why?
|
Drug Evaluation | 1 | 2005 | 642 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2010 | 1183 | 0.050 |
Why?
|
Drugs, Essential | 1 | 2024 | 70 | 0.050 |
Why?
|
Case Management | 1 | 2005 | 272 | 0.050 |
Why?
|
Pirenzepine | 1 | 2003 | 116 | 0.050 |
Why?
|
Interpersonal Relations | 1 | 2011 | 1432 | 0.050 |
Why?
|
S-Adenosylhomocysteine | 5 | 1984 | 41 | 0.050 |
Why?
|
Temperament | 1 | 2005 | 295 | 0.050 |
Why?
|
Quantitative Trait, Heritable | 1 | 2006 | 539 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2003 | 411 | 0.050 |
Why?
|
Social Adjustment | 5 | 2011 | 632 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2006 | 634 | 0.050 |
Why?
|
Homocysteine | 5 | 1984 | 638 | 0.050 |
Why?
|
Polymorphism, Genetic | 2 | 2011 | 4282 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2003 | 415 | 0.050 |
Why?
|
Pain | 1 | 2017 | 5063 | 0.050 |
Why?
|
Psychology | 1 | 2024 | 355 | 0.050 |
Why?
|
Corpus Striatum | 1 | 2008 | 1233 | 0.050 |
Why?
|
Peripartum Period | 1 | 2023 | 137 | 0.050 |
Why?
|
Puberty | 1 | 2005 | 499 | 0.050 |
Why?
|
Dizziness | 2 | 2006 | 257 | 0.050 |
Why?
|
Pharmacogenetics | 1 | 2006 | 675 | 0.050 |
Why?
|
Drug Synergism | 1 | 2005 | 1746 | 0.050 |
Why?
|
Reproducibility of Results | 6 | 2015 | 20037 | 0.050 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7796 | 0.050 |
Why?
|
Models, Psychological | 1 | 2005 | 829 | 0.050 |
Why?
|
Research Design | 4 | 2024 | 6152 | 0.050 |
Why?
|
Brain | 9 | 2010 | 26952 | 0.050 |
Why?
|
Causality | 1 | 2007 | 1239 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2009 | 4553 | 0.050 |
Why?
|
Risk Assessment | 4 | 2019 | 23816 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2847 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2003 | 604 | 0.050 |
Why?
|
Age Distribution | 2 | 2004 | 2877 | 0.050 |
Why?
|
Receptors, Presynaptic | 1 | 2000 | 15 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10634 | 0.050 |
Why?
|
Receptors, Catecholamine | 1 | 2000 | 6 | 0.040 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2005 | 487 | 0.040 |
Why?
|
Area Under Curve | 2 | 2003 | 1632 | 0.040 |
Why?
|
Automobile Driving | 1 | 2005 | 439 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 1 | 1990 | 2248 | 0.040 |
Why?
|
Regression Analysis | 4 | 2003 | 6337 | 0.040 |
Why?
|
Anger | 1 | 2022 | 402 | 0.040 |
Why?
|
Cholinergic Agonists | 1 | 1999 | 75 | 0.040 |
Why?
|
Prefrontal Cortex | 2 | 2008 | 2209 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2024 | 0.040 |
Why?
|
Appetite | 2 | 2017 | 247 | 0.040 |
Why?
|
Echocardiography | 1 | 2012 | 4963 | 0.040 |
Why?
|
Aged | 7 | 2023 | 167890 | 0.040 |
Why?
|
Smoking Cessation | 2 | 2008 | 2045 | 0.040 |
Why?
|
New York City | 1 | 2021 | 726 | 0.040 |
Why?
|
Tandem Repeat Sequences | 1 | 1999 | 180 | 0.040 |
Why?
|
Receptors, Dopamine | 1 | 1999 | 293 | 0.040 |
Why?
|
Anticonvulsants | 2 | 2006 | 1882 | 0.040 |
Why?
|
Electric Stimulation Therapy | 1 | 2024 | 613 | 0.040 |
Why?
|
Forecasting | 2 | 2005 | 2919 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 487 | 0.040 |
Why?
|
Phenotype | 4 | 2008 | 16533 | 0.040 |
Why?
|
Continuity of Patient Care | 1 | 2005 | 1067 | 0.040 |
Why?
|
Disulfiram | 1 | 1998 | 63 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1568 | 0.040 |
Why?
|
Genetic Testing | 1 | 2011 | 3529 | 0.040 |
Why?
|
Social Stigma | 1 | 2024 | 762 | 0.040 |
Why?
|
Patient Compliance | 2 | 2005 | 2685 | 0.040 |
Why?
|
Risperidone | 1 | 1999 | 379 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2022 | 869 | 0.030 |
Why?
|
Attitude | 1 | 2022 | 776 | 0.030 |
Why?
|
Genome-Wide Association Study | 3 | 2011 | 12601 | 0.030 |
Why?
|
Medical Records | 3 | 1999 | 1406 | 0.030 |
Why?
|
Sympatholytics | 1 | 1996 | 82 | 0.030 |
Why?
|
Growth | 1 | 1998 | 365 | 0.030 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2016 | 109 | 0.030 |
Why?
|
Prognosis | 5 | 2008 | 29488 | 0.030 |
Why?
|
Psychological Techniques | 1 | 2016 | 48 | 0.030 |
Why?
|
Drug Users | 1 | 2018 | 134 | 0.030 |
Why?
|
Nerve Net | 1 | 2008 | 2264 | 0.030 |
Why?
|
Self-Assessment | 1 | 1998 | 393 | 0.030 |
Why?
|
Live Birth | 1 | 2019 | 512 | 0.030 |
Why?
|
Clinical Protocols | 2 | 1998 | 1436 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2769 | 0.030 |
Why?
|
Environment | 1 | 2002 | 1117 | 0.030 |
Why?
|
Lithium | 1 | 1998 | 596 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2018 | 299 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 1998 | 538 | 0.030 |
Why?
|
Child Welfare | 1 | 1999 | 515 | 0.030 |
Why?
|
Hospitals, General | 1 | 2019 | 795 | 0.030 |
Why?
|
Verbal Learning | 2 | 2008 | 463 | 0.030 |
Why?
|
Probability | 2 | 1997 | 2462 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 1995 | 289 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3097 | 0.030 |
Why?
|
Nerve Tissue Proteins | 3 | 1984 | 4407 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2020 | 815 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 820 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 758 | 0.030 |
Why?
|
Pediatrics | 1 | 2009 | 3586 | 0.030 |
Why?
|
Nuclear Family | 2 | 2009 | 312 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1703 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2005 | 1919 | 0.030 |
Why?
|
Frontal Lobe | 1 | 2000 | 1419 | 0.030 |
Why?
|
Internal-External Control | 1 | 1995 | 359 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2014 | 352 | 0.030 |
Why?
|
Fear | 1 | 2022 | 1463 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3562 | 0.030 |
Why?
|
Adenosine | 5 | 1984 | 802 | 0.030 |
Why?
|
Linear Models | 4 | 2011 | 5856 | 0.030 |
Why?
|
Colic | 1 | 2012 | 44 | 0.030 |
Why?
|
Language | 1 | 2022 | 1529 | 0.030 |
Why?
|
Thyroid Diseases | 1 | 1995 | 386 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 3670 | 0.020 |
Why?
|
Patient Selection | 1 | 2024 | 4235 | 0.020 |
Why?
|
Semaphorin-3A | 1 | 2011 | 39 | 0.020 |
Why?
|
Biological Availability | 1 | 2012 | 390 | 0.020 |
Why?
|
Epidemics | 1 | 2017 | 512 | 0.020 |
Why?
|
Caregivers | 1 | 2023 | 2224 | 0.020 |
Why?
|
Psychology, Social | 1 | 2011 | 52 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 1000 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15207 | 0.020 |
Why?
|
Cardiac Complexes, Premature | 1 | 1990 | 63 | 0.020 |
Why?
|
Sialoglycoproteins | 1 | 2011 | 315 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1993 | 916 | 0.020 |
Why?
|
S-Adenosylmethionine | 4 | 1984 | 213 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3861 | 0.020 |
Why?
|
Mental Health | 1 | 2024 | 3228 | 0.020 |
Why?
|
Sensory Gating | 1 | 2008 | 47 | 0.020 |
Why?
|
Child Development | 1 | 2000 | 2286 | 0.020 |
Why?
|
Family Relations | 1 | 2011 | 317 | 0.020 |
Why?
|
Liver | 2 | 2003 | 7502 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1088 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2024 | 4456 | 0.020 |
Why?
|
Ammonia | 1 | 2009 | 236 | 0.020 |
Why?
|
Heart Block | 1 | 1990 | 392 | 0.020 |
Why?
|
Psychomotor Performance | 2 | 2007 | 1878 | 0.020 |
Why?
|
Methylation | 4 | 1984 | 1078 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9298 | 0.020 |
Why?
|
Vital Signs | 1 | 2009 | 144 | 0.020 |
Why?
|
Pre-Excitation Syndromes | 1 | 2008 | 27 | 0.020 |
Why?
|
Self Disclosure | 1 | 2009 | 249 | 0.020 |
Why?
|
Hospitals, University | 1 | 2009 | 564 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2005 | 5382 | 0.020 |
Why?
|
Chest Pain | 1 | 2014 | 1090 | 0.020 |
Why?
|
Heart Ventricles | 2 | 1990 | 3806 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 795 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 389 | 0.020 |
Why?
|
Histamine | 3 | 1984 | 497 | 0.020 |
Why?
|
California | 1 | 2011 | 1418 | 0.020 |
Why?
|
Genotype | 3 | 2010 | 12951 | 0.020 |
Why?
|
Cause of Death | 1 | 1997 | 3667 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1617 | 0.020 |
Why?
|
Systole | 1 | 2009 | 935 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2009 | 1628 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1344 | 0.020 |
Why?
|
Diastole | 1 | 2009 | 781 | 0.020 |
Why?
|
Piperazines | 1 | 1997 | 2511 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 514 | 0.020 |
Why?
|
Problem Solving | 1 | 2008 | 440 | 0.020 |
Why?
|
Radioimmunoassay | 2 | 1985 | 866 | 0.020 |
Why?
|
Hematocrit | 1 | 2007 | 625 | 0.020 |
Why?
|
Anorexia | 1 | 2006 | 154 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 437 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 1990 | 465 | 0.020 |
Why?
|
Blood Cells | 1 | 2007 | 305 | 0.020 |
Why?
|
Disease Progression | 4 | 2005 | 13463 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23335 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 36270 | 0.020 |
Why?
|
Diplopia | 1 | 2006 | 215 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2007 | 999 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2010 | 15774 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2009 | 1703 | 0.010 |
Why?
|
Methylhistamines | 1 | 1984 | 4 | 0.010 |
Why?
|
Reaction Time | 2 | 2008 | 2076 | 0.010 |
Why?
|
Hepatitis C | 1 | 2014 | 1579 | 0.010 |
Why?
|
Databases, Factual | 1 | 2020 | 7927 | 0.010 |
Why?
|
Methionine | 2 | 1984 | 569 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1623 | 0.010 |
Why?
|
Aging | 1 | 2003 | 8654 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6956 | 0.010 |
Why?
|
Adenosine Deaminase Inhibitors | 1 | 1982 | 9 | 0.010 |
Why?
|
Nucleoside Deaminases | 1 | 1982 | 58 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1983 | 366 | 0.010 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2003 | 107 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2005 | 986 | 0.010 |
Why?
|
Dysthymic Disorder | 1 | 2002 | 75 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9263 | 0.010 |
Why?
|
Movement Disorders | 1 | 2006 | 459 | 0.010 |
Why?
|
Biogenic Amines | 1 | 1981 | 53 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2005 | 1567 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 1985 | 551 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3238 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2540 | 0.010 |
Why?
|
Tics | 1 | 2001 | 74 | 0.010 |
Why?
|
Polyamines | 1 | 1981 | 133 | 0.010 |
Why?
|
Cross Reactions | 1 | 1983 | 818 | 0.010 |
Why?
|
Neurons | 1 | 2000 | 9418 | 0.010 |
Why?
|
Phospholipids | 2 | 1983 | 784 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2717 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1985 | 699 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2008 | 1502 | 0.010 |
Why?
|
Genetic Variation | 2 | 2010 | 6549 | 0.010 |
Why?
|
Animals | 7 | 2007 | 167718 | 0.010 |
Why?
|
Diseases in Twins | 1 | 2002 | 447 | 0.010 |
Why?
|
Remission, Spontaneous | 1 | 2000 | 384 | 0.010 |
Why?
|
Dopamine Agents | 1 | 2000 | 189 | 0.010 |
Why?
|
Seizures | 2 | 1983 | 2919 | 0.010 |
Why?
|
Benzhydryl Compounds | 1 | 2006 | 900 | 0.010 |
Why?
|
Physician's Role | 1 | 2006 | 916 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1981 | 551 | 0.010 |
Why?
|
Headache | 1 | 2006 | 1249 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12047 | 0.010 |
Why?
|
Epinephrine | 1 | 1981 | 790 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2002 | 1373 | 0.010 |
Why?
|
Pancreatitis | 1 | 2003 | 1096 | 0.010 |
Why?
|
Recurrence | 2 | 1999 | 8426 | 0.010 |
Why?
|
Lung | 1 | 2014 | 9973 | 0.010 |
Why?
|
Multigene Family | 1 | 1999 | 1076 | 0.010 |
Why?
|
Brain Stem | 1 | 1981 | 857 | 0.010 |
Why?
|
Memory | 1 | 2005 | 2179 | 0.010 |
Why?
|
Thyroid Hormone Resistance Syndrome | 1 | 1995 | 15 | 0.010 |
Why?
|
Education, Special | 1 | 1995 | 86 | 0.010 |
Why?
|
Weight Loss | 1 | 2006 | 2672 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2008 | 2741 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2011 | 7840 | 0.010 |
Why?
|
Marital Status | 1 | 1995 | 426 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 1999 | 1996 | 0.010 |
Why?
|
Triiodothyronine | 1 | 1995 | 493 | 0.010 |
Why?
|
Genetic Markers | 1 | 1999 | 2608 | 0.010 |
Why?
|
Adenosylhomocysteinase | 2 | 1982 | 3 | 0.010 |
Why?
|
Thyrotropin | 1 | 1995 | 832 | 0.010 |
Why?
|
Thyroxine | 1 | 1995 | 667 | 0.010 |
Why?
|
Syndrome | 1 | 1998 | 3261 | 0.010 |
Why?
|
Hydrolases | 2 | 1982 | 146 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2003 | 2475 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1982 | 4737 | 0.010 |
Why?
|
Alleles | 1 | 1999 | 6894 | 0.000 |
Why?
|
Survival Analysis | 1 | 1998 | 10075 | 0.000 |
Why?
|
Sleep | 1 | 2001 | 4745 | 0.000 |
Why?
|
Data Collection | 1 | 1995 | 3319 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1996 | 2629 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1982 | 10167 | 0.000 |
Why?
|
Quality of Life | 1 | 2005 | 13263 | 0.000 |
Why?
|
Mice | 4 | 1984 | 81066 | 0.000 |
Why?
|
Deoxyadenosines | 1 | 1982 | 27 | 0.000 |
Why?
|
Peromyscus | 1 | 1981 | 16 | 0.000 |
Why?
|
Putrescine | 1 | 1981 | 42 | 0.000 |
Why?
|
Spermidine | 1 | 1981 | 61 | 0.000 |
Why?
|
Histamine N-Methyltransferase | 1 | 1981 | 3 | 0.000 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 1981 | 18 | 0.000 |
Why?
|
Spermine | 1 | 1981 | 69 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1983 | 1758 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1995 | 14637 | 0.000 |
Why?
|
Brain Chemistry | 1 | 1983 | 959 | 0.000 |
Why?
|
Acoustic Stimulation | 1 | 1981 | 1232 | 0.000 |
Why?
|
Adenine | 1 | 1982 | 975 | 0.000 |
Why?
|
Cell Division | 1 | 1982 | 4459 | 0.000 |
Why?
|
Circadian Rhythm | 1 | 1981 | 2568 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1982 | 18936 | 0.000 |
Why?
|
Rats | 1 | 1981 | 23676 | 0.000 |
Why?
|